JournalTOCs

Circulation : Cardiovascular Imaging
Journal Prestige (SJR): 3.242

Citation Impact (citeScore): 4
Number of Followers: 17

Hybrid journal (It can contain Open Access articles)
ISSN (Print) 1941-9651 - ISSN (Online) 1942-0080
Published by American Heart Association

[12 journals]

Spatially Weighted Coronary Artery Calcium Score and Coronary Heart
Disease Events in the Multi-Ethnic Study of Atherosclerosis
- Authors: Steven Shea Ana Navas-Acien Daichi Shimbo Elizabeth R. Brown Matthew Budoff Michael P. Bancks R. Graham Barr Richard Kronmal Department of Medicine; Vagelos College of Physicians Prevention, Wake Forest School of Medicine, Winston-Salem, NC (M.P.B.).
  Abstract: Circulation: Cardiovascular Imaging, Volume 14, Issue 1, January 1, 2021.
  Background:A limitation of the Agatston coronary artery calcium (CAC) score is that it does not use all of the calcium density information in the computed tomography scan such that many individuals have a score of zero. We examined the predictive validity for incident coronary heart disease (CHD) events of the spatially weighted coronary calcium score (SWCS), an alternative scoring method for CAC that assigns scores to individuals with Agatston CAC=0.Methods:The MESA (Multi-Ethnic Study of Atherosclerosis) is a longitudinal study that conducted a baseline exam from 2000 to 2002 in 6814 participants including computed tomography scanning for CAC. Subsequent exams and systematic follow-up of the cohort for outcomes were performed. Statistical models were adjusted using the MESA risk score based on age, sex, race/ethnicity, systolic blood pressure, use of hypertension medications, diabetes, total and HDL (high-density lipoprotein) cholesterol, use of lipid-lowering medications, smoking status, and family history of heart attack.Results:In the 3286 participants with Agatston CAC=0 at baseline and for whom SWCS was computed, 98 incident CHD events defined as definite or probably myocardial infarction or definite CHD death occurred during a median follow-up of 15.1 years. In this group, SWCS predicted incident CHD events after multivariable adjustment (hazard ratio=1.30 per SD of natural logarithm [SWCS] [95% CI, 1.04–1.60];P=0.005); and progression from Agatston CAC=0 at baseline to CAC>0 at subsequent exams (multivariable-adjusted incidence rate difference per SD of natural logarithm [SWCS] per 100 person-years 1.68 [95% CI, 1.03–2.33];P<0.0001).Conclusions:SWCS predicts incident CHD events in individuals with Agatston CAC score=0 as well as conversion to Agatston CAC>0 at repeat computed tomography scanning at later exams. SWCS has predictive validity as a subclinical phenotype and marker of CHD risk in individuals with Agatston CAC=0.
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-19T10:00:56Z
  DOI: 10.1161/CIRCIMAGING.120.011981
  Issue No: Vol. 14, No. 1 (2021)
Higher Acceleration/Ejection Time Ratio Predicts Impaired Outcome in
Aortic Valve Stenosis
- Authors: Eigir Einarsen Dana Cramariuc Edda Bahlmann Helga Midtbo John B. Chambers Eva Gerdts Department of Clinical Science; University of Bergen, Norway (E.E., E.G.). Department of Heart Disease, Haukeland University Hospital, Bergen, Norway (D.C., H.M., E.G.). Department of Cardiology, Asklepios Clinic St. Georg, Hamburg, Germany (E.B.). Cardiothoracic Centre, Guys St. Thomas Hospitals, London, United Kingdom (J.B.C.).
  Abstract: Circulation: Cardiovascular Imaging, Volume 14, Issue 1, January 1, 2021.
  Background:Acceleration time (AT)/ejection time (ET) ratio is a marker of aortic valve stenosis (AS) severity and predicts outcome in moderate-severe AS.Methods:We explored the association of increased AT/ET ratio on prognosis in 1530 asymptomatic patients with presumably mild-moderate AS, normal ejection fraction, and without known diabetes or cardiovascular disease. Patients were part of the SEAS study (Simvastatin Ezetimibe Aortic Stenosis). Patients were grouped according to the optimal AT/ET ratio threshold to predict cardiovascular death and heart failure hospitalization. Low-gradient severe AS was identified as combined valve area ≤1.0 cm2and mean gradient <40 mm Hg. Outcome was assessed in Cox regression analyses, and results are reported as hazard ratio and 95% CI.Results:Higher AT/ET ratio was significantly associated with lower systolic blood pressure, lower left ventricular ejection fraction, lower stress-corrected midwall shortening, low flow, and with higher left ventricular mass and higher peak aortic jet velocity. AT/ET ratio ≥0.32 provided the optimal cutoff for predicting incident cardiovascular death and heart failure hospitalization in the total study sample. In patients with low-gradient severe AS, this threshold was >0.32. AT/ET ratio ≥0.32 had a 79% higher risk of cardiovascular death and heart failure hospitalization (hazard ratio, 1.79 [95% CI, 1.20–2.68]). In patients with low-gradient severe AS, AT/ET ratio >0.32 was associated with a 2-fold higher risk of cardiovascular death and heart failure hospitalization (hazard ratio, 2.15 [95% CI, 1.22–3.77]).Conclusions:In asymptomatic nonsevere AS and low-gradient severe AS, higher AT/ET ratio was associated with increased cardiovascular morbidity and mortality.Registration:URL:https://www.clinicaltrials.gov; Unique identifier: NCT00092677.
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-19T10:00:45Z
  DOI: 10.1161/CIRCIMAGING.120.011467
  Issue No: Vol. 14, No. 1 (2021)
Spatially Weighted Calcium Score Beyond Power of Zero
- Authors: Marcio Sommer Bittencourt Khurram Nasir Center for Clinical; Vascular Center, Houston, TX (K.N.). Center for Outcomes Research, The Houston Methodist Research Institute, Houston, TX (K.N.).
  Abstract: Circulation: Cardiovascular Imaging, Volume 14, Issue 1, January 1, 2021.
  
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-19T10:00:34Z
  DOI: 10.1161/CIRCIMAGING.120.012236
  Issue No: Vol. 14, No. 1 (2021)
Building Experience and Evidence
- Authors: Amanda K. Verma Justin M. Vader Section of Heart Failure; Cardiac Transplantation, Cardiovascular Division, Department of Medicine, Washington University School of Medicine, St. Louis, MO.
  Abstract: Circulation: Cardiovascular Imaging, Volume 14, Issue 1, January 1, 2021.
  
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-19T10:00:33Z
  DOI: 10.1161/CIRCIMAGING.120.012220
  Issue No: Vol. 14, No. 1 (2021)
Left Atrial Volumetric/Mechanical Coupling Index
- Authors: Giovanni Benfari Benjamin Essayagh Stefano Nistri Joseph Maalouf Andrea Rossi Prabin Thapa Hector I. Michelena Maurice Enriquez-Sarano Department of Cardiovascular Diseases, Mayo Clinic, Mayo Clinic, Rochester, MN (G.B; B.E, J.M, P.T, H.I.M, M.E.-S.). University of Verona, Section of Cardiology, Department of Medicine, Italy (G.B, A.R.). CMSR Veneto Medica, Cardiology Service, Altavilla Vicentina, Vicenza, Italy (S.N.).
  Abstract: Circulation: Cardiovascular Imaging, Volume 14, Issue 1, January 1, 2021.
  Background:Left atrial assessment is complex, particularly in heart failure with reduced ejection fraction due to interactions with functional mitral regurgitation (FMR). Pilot data suggest that left atrial volumetric/mechanical coupling index (LACI) may be useful, but large outcome data are lacking.Methods:We enrolled a comprehensively characterized cohort of patients in sinus rhythm with heart failure with reduced ejection fraction diagnosis at Mayo Clinic from 2007 to 2011. Routinely measured left atrial volume index and tissue-doppler-imaging a’ allowed LACI calculation as (left atrial volume index)/(tissue-doppler-imaging a’). Survival was the outcome measured.Results:The cohort’s 4196 patients (69 [58–77] years, ejection fraction 40 [31–45]%) had mild FMR in 1505 and moderate-severe FMR in 1068. LACI was overall 5.06 (3.50–8.10) and increased with each FMR grade (3.86 [2.94–5.29] without FMR, 5.38 [3.80–8.02] with mild, 5.45 [1.49–8.07] with moderate/severe FMR;P<0.0001). At diagnosis, higher LACI was independently determined by more severe FMR and by higher left ventricular mass index, lower ejection fraction, higher E/e’, and lower glomerular filtration rate (allP<0.0001). During follow-up 1588 (38%) patients died. In spline modeling, excess mortality appeared around LACI=6 and steeply increased thereafter (5-year survival 72±1% with LACI<6 and 49±2% with LACI ≥6,P<0.0001). Multivariable comprehensive adjustment showed LACI strong association with excess mortality (adjusted hazard ratio, 1.41 [1.23–1.61],P<0.0001 for LACI ≥6). Independent link to mortality persistent across FMR grades (adjusted hazard ratio, 1.45 [1.13–1.86],P=0.004 without FMR, 1.42 [1.16–1.77],P=0.0008 with mild FMR, and 1.38 [1.01–1.66],P=0.04 with moderate/severe FMR) without interaction (P=0.3). LACI independent impact on outcome was incremental to that of left atrial volume index, tissue-doppler-imaging a’, or any other characteristic including the Meta-Analysis Global Group in Chronic-score (least significantP=0.02).Conclusions:In this large cohort, left atrial volumetric/mechanical coupling measured by LACI in routine practice integrates the influence of several morphological/hemodynamic determinants but displays progressive deterioration with increasing FMR severity in heart failure with reduced ejection fraction. About outcome, higher LACI is strongly, independently, and incrementally associated with excess mortality, irrespective of FMR grade and in all subsets. Hence, LACI is a novel and critical measure in heart failure with reduced ejection fraction, quantifiable in routine practice, which should be integrated in prognostication and decision-making.
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-19T10:00:06Z
  DOI: 10.1161/CIRCIMAGING.120.011608
  Issue No: Vol. 14, No. 1 (2021)
Myocardial Inflammation and Dysfunction in COVID-19–Associated
Myocardial Injury
- Authors: Ludwig T. Weckbach Adrian Curta Stephanie Bieber Angelina Kraechan Johannes Brado Johannes C. Hellmuth Maximilian Muenchhoff Clemens Scherer Ines Schroeder Michael Irlbeck Stefan Maurus Jens Ricke Karin Klingel Stefan Kääb Mathias Orban Steffen Massberg Jörg Hausleiter Ulrich Grabmaier Medical Department I (L.T.W.; S.B., A.K., J.B., C.S., S.K., M.O., S. Massberg, J.H., U.G.), Ludwig-Maximilians-University, Munich, Germany. Department of Radiology (A.C., S. Maurus, J.R.), Ludwig-Maximilians-University, Munich, Germany. Medical Department III (J.C.H.), Ludwig-Maximilians-University, Munich, Germany. Department of Anaesthesiology (I.S., M.I.), Ludwig-Maximilians-University, Munich, Germany. Institute of Cardiovascular Physiology Neuropathology, University Hospital Tuebingen, Germany (K.K.).
  Abstract: Circulation: Cardiovascular Imaging, Volume 14, Issue 1, January 1, 2021.
  Background:Myocardial injury, defined by elevated troponin levels, is associated with adverse outcome in patients with coronavirus disease 2019 (COVID-19). The frequency of cardiac injury remains highly uncertain and confounded in current publications; myocarditis is one of several mechanisms that have been proposed.Methods:We prospectively assessed patients with myocardial injury hospitalized for COVID-19 using transthoracic echocardiography, cardiac magnetic resonance imaging, and endomyocardial biopsy.Results:Eighteen patients with COVID-19 and myocardial injury were included in this study. Echocardiography revealed normal to mildly reduced left ventricular ejection fraction of 52.5% (46.5%–60.5%) but moderately to severely reduced left ventricular global longitudinal strain of −11.2% (−7.6% to −15.1%). Cardiac magnetic resonance showed any myocardial tissue injury defined by elevated T1, extracellular volume, or late gadolinium enhancement with a nonischemic pattern in 16 patients (83.3%). Seven patients (38.9%) demonstrated myocardial edema in addition to tissue injury fulfilling the Lake-Louise criteria for myocarditis. Combining cardiac magnetic resonance with speckle tracking echocardiography demonstrated functional or morphological cardiac changes in 100% of investigated patients. Endomyocardial biopsy was conducted in 5 patients and revealed enhanced macrophage numbers in all 5 patients in addition to lymphocytic myocarditis in 1 patient. SARS-CoV-2 RNA was not detected in any biopsy by quantitative real-time polymerase chain reaction. Finally, follow-up measurements of left ventricular global longitudinal strain revealed significant improvement after a median of 52.0 days (−11.2% [−9.2% to −14.7%] versus −15.6% [−12.5% to −19.6%] at follow-up;P=0.041).Conclusions:In this small cohort of COVID-19 patients with elevated troponin levels, myocardial injury was evidenced by reduced echocardiographic left ventricular strain, myocarditis patterns on cardiac magnetic resonance, and enhanced macrophage numbers but not predominantly lymphocytic myocarditis in endomyocardial biopsies.
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-19T10:00:05Z
  DOI: 10.1161/CIRCIMAGING.120.011713
  Issue No: Vol. 14, No. 1 (2021)
Left Atrial Coupling Index and Its Prognostic Value in Heart Failure With
Reduced Ejection Fraction
- Authors: Mahesh K. Vidula Julio A. Chirinos Division of Cardiovascular Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA (M.K.V; J.A.C.). University of Pennsylvania Perelman School of Medicine, Philadelphia, PA (J.A.C.).
  Abstract: Circulation: Cardiovascular Imaging, Volume 14, Issue 1, January 1, 2021.
  
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-19T10:00:05Z
  DOI: 10.1161/CIRCIMAGING.120.012221
  Issue No: Vol. 14, No. 1 (2021)
Acceleration Time in Aortic Stenosis
- Authors: Sylvestre Maréchaux Christophe Tribouilloy Groupement des Hôpitaux de l’Institut Catholique de Lille, Department of Cardiology, Lille Catholic University, France (S.M.). Department of Cardiology, Amiens University Hospital, France (C.T.). UR UPJV 7517, Jules Verne University of Picardie, Amiens, France (S.M; C.T.).
  Abstract: Circulation: Cardiovascular Imaging, Volume 14, Issue 1, January 1, 2021.
  
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-19T10:00:03Z
  DOI: 10.1161/CIRCIMAGING.120.012234
  Issue No: Vol. 14, No. 1 (2021)
Left Circumflex Artery-Left Atria Fistula Treated With Transcatheter
Closure
- Authors: Xiao-Feng Zhuang Jing Ping Sun Zhi-Hui Hou Mu-Zi Li Xiao-Lu Sun Department of Cardiology (X.-F.Z.; J.P.S., X.-L.S.), National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences Peking Union Medical College, Fuwai Hospital, China.
  Abstract: Circulation: Cardiovascular Imaging, Volume 14, Issue 1, January 1, 2021.
  
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-18T10:00:39Z
  DOI: 10.1161/CIRCIMAGING.120.010913
  Issue No: Vol. 14, No. 1 (2021)
Myocardial Ischemia in the Management of Chronic Coronary Artery Disease
- Authors: Raymond J. Gibbons Department of Cardiovascular Medicine; Mayo Clinic, Rochester, MN.
  Abstract: Circulation: Cardiovascular Imaging, Volume 14, Issue 1, January 1, 2021.
  For many years, stress-induced myocardial ischemia has been considered important in the management of chronic coronary artery disease. Early evidence focused on the exercise ECG and the Duke treadmill score. In the 1970s, randomized clinical trials, which compared coronary artery bypass surgery to medical therapy, enrolled patients who were very different from contemporary practice and had inconsistent results. Surgery appeared to be of greatest benefit in high-risk patients defined by anatomy (such as left main disease) or stress-induced ischemia. However, randomized clinical trials of revascularization versus contemporary medical therapy over the past 20 years have been surprisingly negative. Nuclear cardiology substudies from these trials reported inconsistent results. Two observational studies from a single-center provided the best evidence for the use of stress-induced ischemia to identify patients who were most likely to benefit from revascularization. The recently completed ISCHEMIA trial (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches) was designed to test the hypothesis that revascularization would improve outcomes in patients with moderate-severe ischemia on stress testing. Unfortunately, 14.2% of the randomized patients had either mild or no ischemia on core lab review. Nearly one-quarter of the patients were randomized on the basis of an exercise ECG without imaging. The negative results of the trial reflect the long-term population decline in coronary artery disease and abnormal stress tests, as well as improvements in patient outcome due to optimal medical therapy. Topics requiring further research are presented. The implications of the trial for the use of both stress imaging and coronary computed tomography angiography in clinical practice are examined.
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-18T10:00:24Z
  DOI: 10.1161/CIRCIMAGING.120.011615
  Issue No: Vol. 14, No. 1 (2021)
ISCHEMIA Trial
- Authors: Rory Hachamovitch Prem Soman Cardiovascular Imaging Section; Department of Cardiovascular Medicine, Heart Vascular Institute, Cleveland Clinic Foundation, OH (R.H.). University of Pittsburgh, PA (P.S.).
  Abstract: Circulation: Cardiovascular Imaging, Volume 14, Issue 1, January 1, 2021.
  
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-18T10:00:02Z
  DOI: 10.1161/CIRCIMAGING.120.012319
  Issue No: Vol. 14, No. 1 (2021)
Prognostic Impact of Late Gadolinium Enhancement by Cardiovascular
Magnetic Resonance in Myocarditis
- Authors: Georgios Georgiopoulos Stefano Figliozzi Francesca Sanguineti Giovanni Donato Aquaro Gianluca di Bella Kimon Stamatelopoulos Amedeo Chiribiri Jerome Garot Pier Giorgio Masci Tevfik F. Ismail School of Biomedical Engineering & Imaging Sciences; King’s College London, United Kingdom (G.G., S.F., A.C., P.G.M., T.F.I.). Department of Clinical Therapeutics, National Pharmacology, University of Messina, Italy (G.d.B.).
  Abstract: Circulation: Cardiovascular Imaging, Ahead of Print.
  BackgroundPatients with acute myocarditis (AM) are at increased risk of adverse cardiac events after the index episode. Late gadolinium enhancement (LGE) detected by cardiovascular magnetic resonance in patients with AM plays an important diagnostic role, but its prognostic significance remains unresolved. This systematic review and meta-analysis sought to assess the prognostic implications of cardiovascular magnetic resonance-derived LGE in patients with AM.MethodsData search was conducted from inception through February 28, 2020, using the following Medical Subject Heading terms:Myocarditis, CMR, Magnetic Resonance Imaging, Magnetic Resonance. From 2422 articles retrieved, we selected 11 studies reporting baseline cardiovascular magnetic resonance assessment and long-term clinical follow-up in patients with AM. Hazard ratios and CIs for a combined clinical end point were recorded for LGE presence, extent (>2 segments or >10% of left ventricular [LV] mass or >17g) and location (anteroseptal versus non-anteroseptal). A combined end point comprised all-cause mortality, cardiac mortality, and major adverse cardiovascular events. Hartung and Knapp correction improved robustness of the results. Prespecified sensitivity analyses explored potential sources of heterogeneity. The meta-analysis was conducted according to the Meta-analysis of Observational Studies in Epidemiology guidelines.ResultsLGE presence (pooled hazard ratios, 3.28 [95% CIs, 1.69–6.39],P<0.001 [95% CIs, 1.33–8.11] after Hartung and Knapp correction) and anteroseptal LGE (pooled-hazard ratios, 2.58 [95% CIs, 1.87–3.55],P<0.001 [95% CIs, 1.64–4.06] after Hartung and Knapp correction) were associated with an increased risk of the combined end point. Extensive LGE was associated with worse outcomes (pooled-hazard ratios, 1.96 [95% CIs, 1.08–3.56],P=0.027), but this association was not confirmed after Hartung and Knapp correction (95% CIs, 0.843–4.57).ConclusionsLGE presence and anteroseptal location at baseline cardiovascular magnetic resonance are important independent prognostic markers that herald an increased risk of adverse cardiac outcomes in patients with AM.REGISTRATION:https://www.crd.york.ac.uk/PROSPERO/Unique identifier: CRD42019146619.
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-14T10:00:02Z
  DOI: 10.1161/CIRCIMAGING.120.011492
Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance
on Mortality and Heart Failure Hospitalization in Patients With Advanced
Heart Failure and Reduced Ejection Fraction
- Authors: Laura Houard Mihaela S. Amzulescu Geoffrey Colin Helene Langet Sebastian Militaru Michel F. Rousseau Sylvie A. Ahn Jean-Louis J. Vanoverschelde Anne-Catherine Pouleur Bernhard L. Gerber Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires St. Luc (L.H; M.S.A, G.C, S.M, M.F.R, S.A.A, J.-L.J.V, A.-C.P, B.L.G.). Pôle de Recherche Cardiovasculaire (CARD), Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium (L.H, M.S.A, S.M, M.F.R, S.A.A, J.-L.J.V, A.-C.P, B.L.G.). Philips Clinical Research Board, Suresnes, France (H.L.).
  Abstract: Circulation: Cardiovascular Imaging, Ahead of Print.
  BackgroundPulmonary transit time (PTT) from first-pass perfusion imaging is a novel parameter to evaluate hemodynamic congestion by cardiac magnetic resonance (cMR). We sought to evaluate the additional prognostic value of PTT in heart failure with reduced ejection fraction over other well-validated predictors of risk including the Meta-Analysis Global Group in Chronic Heart Failure risk score and ischemic cause.MethodsWe prospectively followed 410 patients with chronic heart failure with reduced ejection fraction (61±13 years, left ventricular (LV) ejection fraction 24±7%) who underwent a clinical cMR to assess the prognostic value of PTT for a primary endpoint of overall mortality and secondary composite endpoint of cardiovascular death and heart failure hospitalization. Normal reference values of PTT were evaluated in a population of 40 asymptomatic volunteers free of cardiovascular disease.ResultsPTT was significantly increased in patients with heart failure with reduced ejection fraction as compared to controls (9±6 beats and 7±2 beats, respectively,P<0.001), and correlated not only with New York Heart Association class, cMR–LV and cMR–right ventricular (RV) volumes, cMR-RV and cMR-LV ejection fraction, and feature tracking global longitudinal strain, but also with cardiac output. Over 6-year median follow-up, 182 patients died and 200 reached the secondary endpoint. By multivariate Cox analysis, PTT was an independent and significant predictor of both endpoints after adjustment for Meta-Analysis Global Group in Chronic Heart Failure risk score and ischemic cause. Importantly in multivariable analysis, PTT in beats had significantly higher additional prognostic value to predict not only overall mortality (χ2to improve, 12.3; hazard ratio, 1.35 [95% CI, 1.16–1.58];P<0.001) but also the secondary composite endpoints (χ2to improve=20.1; hazard ratio, 1.23 [95% CI, 1.21–1.60];P<0.001) than cMR-LV ejection fraction, cMR-RV ejection fraction, LV–feature tracking global longitudinal strain, or RV–feature tracking global longitudinal strain. Importantly, PTT was independent and complementary to both pulmonary artery pressure and reduced RV ejection fraction<42% to predict overall mortality and secondary combined endpoints.ConclusionsDespite limitations in temporal resolution, PTT derived from first-pass perfusion imaging provides higher and independent prognostic information in heart failure with reduced ejection fraction than clinical and other cMR parameters, including LV and RV ejection fraction or feature tracking global longitudinal strain.REGISTRATIONURL:https://www.clinicaltrials.gov; Unique identifier: NCT03969394.
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-13T10:00:05Z
  DOI: 10.1161/CIRCIMAGING.120.011680
In This Issue of the Journal
- Authors: Robert J. Gropler Editor in Chief; Circulation: Cardiovascular Imaging
  Abstract: Circulation: Cardiovascular Imaging, Ahead of Print.
  
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-13T10:00:02Z
  DOI: 10.1161/CIRCIMAGING.120.012351
Multimodality Imaging in Endomyocardial Fibrosis: Diagnosis and Assessment
of the Extent of the Disease
- Authors: Daniela do Carmo Rassi Paula Chiavenato Marçal Cecília Beatriz Bittencourt Viana Cruz João Batista Masson Silva Viviane Tiemi Hotta São Francisco de Assis Hospital; Goiânia, Brazil Heart Institute of the University of São Paulo (INCOR/FMUSP), São Paulo, Brazil Federal University of Goiás Clinical Hospital Medical School, Goiânia, Brazil
  Abstract: Circulation: Cardiovascular Imaging, Ahead of Print.
  
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-07T10:00:02Z
  DOI: 10.1161/CIRCIMAGING.120.012093
Computed Tomography-Derived Transesophageal Echocardiographic Views
- Authors: Federico Fortuni Kensuke Hirasawa Ana I. Marques Stephan M. Pio Surenjav Chimed Rodolfo Lustosa Catherina Tjahjadi Xu Wang Jeroen J. Bax Nina Ajmone Marsan Victoria Delgado Department of Cardiology, Leiden University Medical Center, The Netherlands (F.F; K.H, S.M.P, S.C, R.L, C.T, X.W, J.J.B, N.A.M, V.D.). Department of Molecular Medicine, Unit of Cardiology, University of Pavia, Italy (F.F.). Department of Cardiology, Hospital Garcia de Orta, Almada, Portugal (A.I.M.).
  Abstract: Circulation: Cardiovascular Imaging, Ahead of Print.
  
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2021-01-06T07:00:01Z
  DOI: 10.1161/CIRCIMAGING.120.011107
Misleading Echocardiographic Diagnosis of an Infant With Dilated
Cardiomyopathy
- Authors: Yu-Hsuan Liu Shu-Chien Huang Jou-Kou Wang Chun-An Chen Department of Pediatrics; Hualien Tzu Chi Hospital, Hualien, Taiwan (Y.-H.L.). Department of Cardiology, National Taiwan University Children’s Hospital, Taipei (Y.-H.L., J.-K.W., C.-A.C.). Division of Cardiovascular Surgery, Department of Surgery, National Taiwan University Hospital National Taiwan University College of Medicine, Taipei, Taiwan (S.-C.H.). Department of Pediatrics, Medical College, National Taiwan University, Taipei (J.-K.W., C.-A.C.).
  Abstract: Circulation: Cardiovascular Imaging, Ahead of Print.
  
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2020-12-24T03:19:16Z
  DOI: 10.1161/CIRCIMAGING.120.011075
Unexpected Aortitis Mimicking an Ascending Aorta Intramural Hematoma in
Ankylosing Spondylitis
- Authors: Igor Vendramin Monica De Gaspari Andrea Lechiancole Uberto Bortolotti Ugolino Livi Cardiothoracic Department, University Hospital of Udine, Italy. (I.V; A.L, U.B, U.L.) Department of Pathology, University Hospital of Udine, Italy. (M.D.G.)
  Abstract: Circulation: Cardiovascular Imaging, Ahead of Print.
  
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2020-12-24T03:18:28Z
  DOI: 10.1161/CIRCIMAGING.120.011014
Primary Aortic Angiosarcoma Presenting as Progressive Thrombosis of the
Thoracic Aorta
- Authors: Francesco Squizzato Franco Grego Division of Vascular; Public Health, University of Padua, Italy.
  Abstract: Circulation: Cardiovascular Imaging, Ahead of Print.
  
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2020-12-24T03:17:17Z
  DOI: 10.1161/CIRCIMAGING.120.010854
Recurrent Tachyarrhythmia due to Giant Hiatal Hernia
- Authors: Luca Botta Gianluca Folesani Davide Pacini Cardiac Surgery Unit; Cardio-Thoraco-Vascular Department, S. Orsola Hospital, University of Bologna, Italy.
  Abstract: Circulation: Cardiovascular Imaging, Ahead of Print.
  
  Citation: Circulation: Cardiovascular Imaging
  PubDate: 2020-12-24T03:13:28Z
  DOI: 10.1161/CIRCIMAGING.120.010809